BioDelivery Sciences International

BioDelivery Sciences International

BioDelivery Sciences International

BioDelivery Sciences (BDSI®) is a specialty pharmaceutical company with a focus in the areas of pain management and addiction medicine.
Type
B2b
Founded
1997
Follow us
Alexa global traffic share
Twitter followers
Latest funding
Undisclosed amount
Post-IPO debt - 2017
CRG L.P.
Team Size
2
Employees
Post-IPO debt
biospace

BioDelivery Secures Debt Financing With CRG

Xconomy

BDSI Cancer Pain Drug Approved Again, Search Continues for New Partner

Health